We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.52%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$287B
AUM Growth
+$18.5B
(+6.9%)
Cap. Flow
-$4.92B
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
26.06%
Holding
3,383
New
280
Increased
1,384
Reduced
1,249
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$672M |
| 2 |
Applied Materials
AMAT
|
+$241M |
| 3 |
Kenvue
KVUE
|
+$220M |
| 4 |
Salesforce
CRM
|
+$210M |
| 5 |
PayPal
PYPL
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.25B |
| 2 |
Advanced Micro Devices
AMD
|
+$526M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$443M |
| 4 |
Chubb
CB
|
+$335M |
| 5 |
Microsoft
MSFT
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.88% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 11.25% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
5E Advanced Materials
FEAM
$62.3M
| $778K | ﹤0.01% |
10,311
+6,162
| +149% | +$585K |
|
2727
Bridgewater Bancshares
BWB
$603M
| $777K | ﹤0.01% |
78,871
+22,120
| +39% | +$213K |
|
|
KZR
2728
DELISTED
Kezar Life Sciences
KZR
| $772K | ﹤0.01% |
31,515
-23,619
| -43% | -$615K |
|
2729
GrowGeneration
GRWG
$90.7M
| $771K | ﹤0.01% |
226,727
-11,859
| -5% | -$42K |
|
|
THRX
2730
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $770K | ﹤0.01% |
82,478
+60,629
| +277% | +$597K |
|
2731
Harvard Bioscience
HBIO
$29.2M
| $769K | ﹤0.01% |
+14,000
| New | +$768K |
|
|
INZY
2732
DELISTED
Inozyme Pharma
INZY
| $767K | ﹤0.01% |
+137,749
| New | +$814K |
|
2733
Limoneira
LMNR
$251M
| $764K | ﹤0.01% |
+49,114
| New | +$809K |
|
2734
Seer Inc
SEER
$120M
| $762K | ﹤0.01% |
178,357
+1,072
| +0.6% | +$4.19K |
|
|
ATXS
2735
DELISTED
Astria Therapeutics
ATXS
| $761K | ﹤0.01% |
+91,391
| New | +$1.05M |
|
2736
Centrus Energy
LEU
$3.82B
| $756K | ﹤0.01% |
23,215
+2,186
| +10% | +$67.7K |
|
2737
SIGA Technologies
SIGA
$219M
| $756K | ﹤0.01% |
149,649
| – | – |
|
2738
Equity Bancshares
EQBK
$1.05B
| $755K | ﹤0.01% |
33,146
-14,382
| -30% | -$337K |
|
2739
Cartesian Therapeutics
RNAC
$268M
| $753K | ﹤0.01% |
+22,425
| New | +$803K |
|
2740
Star Holdings Shares of Beneficial Interest
STHO
$116M
| $753K | ﹤0.01% |
51,352
-13,701
| -21% | -$217K |
|
2741
Aviat Networks
AVNW
$273M
| $753K | ﹤0.01% |
22,574
-5,982
| -21% | -$190K |
|
2742
Smartbird Inc
BIRD
$22.3M
| $751K | ﹤0.01% |
29,801
-8,725
| -23% | -$218K |
|
2743
Wave Life Sciences
WVE
$1.2B
| $751K | ﹤0.01% |
+206,259
| New | +$833K |
|
2744
SAP
SAP
$238B
| $749K | ﹤0.01% |
5,475
+3,060
| +127% | +$405K |
|
2745
Nautilus Biotechnolgy
NAUT
$115M
| $743K | ﹤0.01% |
191,921
+24,809
| +15% | +$71.5K |
|
2746
Aura Biosciences
AURA
$826M
| $742K | ﹤0.01% |
60,115
+5,824
| +11% | +$62.3K |
|
2747
iShares MSCI Saudi Arabia ETF
KSA
$621M
| $741K | ﹤0.01% |
+17,939
| New | +$732K |
|
2748
EVgo
EVGO
$229M
| $740K | ﹤0.01% |
185,111
| – | – |
|
2749
Hallador Energy
HNRG
$696M
| $740K | ﹤0.01% |
+86,391
| New | +$736K |
|
2750
Distribution Solutions Group
DSGR
$1.61B
| $740K | ﹤0.01% |
28,434
-146
| -0.5% | -$3.43K |
|
Similar funds
VFT
Nuveen's Q2 2023 Portfolio in Review
As of Q2 2023, Nuveen held 3,383 positions worth $287B, up 6.9% from $269B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Nuveen's Q2 2023 filing shows 280 new, 1,384 increased, 1,249 reduced and 179 closed positions. Its largest new stake was Kenvue: 8,445,273 shares worth $223M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2023 buy was Kenvue: 8,445,273 shares worth $223M.
- Nuveen added most to Amazon in Q2 2023, an estimated $672M increase.
- Nuveen's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.25B.
- Nuveen fully exited Qualtrics International Inc. Class A Common Stock in Q2 2023, selling an estimated $130M.
- Nuveen's ten largest holdings make up 26% of its $287B portfolio in Q2 2023.
- Nuveen opened 280 new positions and closed 179 in Q2 2023.
- Nuveen's portfolio value rose 6.9% quarter-over-quarter to $287B.
Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.